These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 710023)

  • 1. Role of aldosterone in the antihypertensive effect of spironolactone in essential hypertension.
    Benraad H; Drayer J; Hoefnagels W; Kloppenborg P; Benraad T
    Clin Pharmacol Ther; 1978 Dec; 24(6):638-43. PubMed ID: 710023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
    Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
    Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
    Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ
    Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A; Feely J
    Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
    Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
    Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone and triamterene in volume-dependent essential hypertension.
    DeCarvalho JG; Emery AC; Frohlich ED
    Clin Pharmacol Ther; 1980 Jan; 27(1):53-6. PubMed ID: 6985854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosteronism in hypertension. The spironolactone response test.
    Spark RF; Melby JC
    Ann Intern Med; 1968 Oct; 69(4):685-91. PubMed ID: 5682243
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone prevents Na+/H+ exchange enhancement in primary aldosteronism.
    Koren W; Koldanov R; Postnov IY; Postnov YV
    Am J Hypertens; 1997 Mar; 10(3):341-5. PubMed ID: 9056693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive responses to spironolactone in normal renin hypertension.
    Ogilvie RI; Piafsky KM; Ruedy J
    Clin Pharmacol Ther; 1978 Nov; 24(5):525-30. PubMed ID: 699476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension.
    Ferguson RK; Turek DM; Rovner DR
    Clin Pharmacol Ther; 1977 Jan; 21(1):62-9. PubMed ID: 318952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of renin-angiotensin-aldosterone system in salt-sensitive hypertension induced by sensory denervation.
    Huang Y; Wang DH
    Am J Physiol Heart Circ Physiol; 2001 Nov; 281(5):H2143-9. PubMed ID: 11668076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
    Hunyor SN; Zweifler AJ; Hansson L; Schork MA; Ellis C
    Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.